ISO 13485: The Quality System Foundation

ISO 13485 is the quality management system standard specific to medical devices, including IVD analyzers and reagents. It is not a product certification but a process certification, meaning it audits how a manufacturer designs, produces, and controls its products. Most regulatory authorities worldwide expect ISO 13485 compliance as a baseline, and many distributors require it as a vendor qualification prerequisite.

When evaluating a Chinese IVD supplier, request the ISO 13485 certificate and verify its scope. The scope should explicitly mention IVD reagent manufacturing or analyzer assembly. A certificate that covers only trading activities or unrelated product lines does not demonstrate manufacturing quality control. Check the certificate against the issuing body database, since forged certificates do circulate in the market.

CE IVD: European Market Access

The CE IVD mark under the EU In Vitro Diagnostic Regulation (IVDR, Regulation 2017/746) is required for selling IVD products in the European Economic Area. Under IVDR, products are classified into Class A, B, C, and D based on risk, with higher classes requiring Notified Body involvement.

For Class B and above, the manufacturer needs a technical documentation file, a performance evaluation report, and Notified Body conformity assessment. Class A low-risk products allow self-declaration but still require registration with the relevant competent authority. Ask your supplier which IVDR class their product falls into and whether their CE certificate is under the older IVDD directive or the current IVDR. IVDD certificates expire, and products relying on them will lose European market access.

FDA 510(k): United States Clearance

For the US market, most IVD analyzers and reagents require a 510(k) premarket notification demonstrating substantial equivalence to a legally marketed predicate device. The 510(k) process requires performance data, including precision, accuracy, analytical sensitivity, and interference studies, typically run at three clinical sites.

Chinese manufacturers with existing 510(k) clearances have already invested significant resources in clinical validation, which reduces regulatory risk for US distributors. Ask whether the 510(k) covers the specific model and reagent formulation you intend to distribute, since modifications to the analyzer or reagent composition may require a new submission.

Aligning Multiple Jurisdictions Simultaneously

Distributors operating across multiple regulatory jurisdictions should map the overlapping requirements early. ISO 13485 satisfies the quality system portion of most registrations, but product-specific certifications remain independent:

CE IVD for Europe requires a technical file and performance evaluation under IVDR
FDA 510(k) for the United States requires predicate comparison and clinical performance data
Other markets may accept CE or FDA approvals under recognition agreements, reducing local testing requirements

Request the supplier's regulatory roadmap listing which markets are currently cleared and which are in progress. A supplier with CE IVD and ISO 13485 but no FDA clearance may still serve European and many emerging markets, but US distribution will require additional timeline and investment. Clarify whether the supplier will support your local registration with the necessary technical files and authorization letters, since some manufacturers restrict documentation access to exclusive distributors only.

15:Tcdf,

Start With Throughput, Not Just Price

When sourcing clinical laboratory analyzers from China, the first specification to pin down is throughput measured in tests per hour. A benchtop hematology analyzer running 60 samples per hour suits a small clinic, but a hospital lab processing 500 plus samples daily needs a floor-standing unit pushing 120 tests per hour or more. Ask the supplier for the maximum and sustainable throughput figures, since s

Clinical Microbiology